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Background: Women with gestational diabetes history are at increased risk for type 2 diabetes. They face specific
challenges for behavioural changes, including childcare responsibilities. The aim of this study is to test a tailored
type 2 diabetes prevention intervention in women within 5 years of a pregnancy with gestational diabetes, in terms
of effects on weight and cardiometabolic risk factors.
Methods: The 13-week intervention, designed based on focus group discussions, included four group sessions, two
with spousal participation and all with on-site childcare. Web/telephone-based support was provided between
sessions. We computed mean percentage change from baseline (95% confidence intervals, CI) for anthropometric
measures, glucose tolerance (75 g Oral glucose tolerance test), insulin resistance/sensitivity, blood pressure, physical
activity, dietary intake, and other cardiometabolic risk factors.
Results: Among the 36 enrolled, 27 completed final evaluations. Most attended ≥ 3 sessions (74%), used on-site
childcare (88%), and logged onto the website (85%). Steps/day (733 steps, 95% CI 85, 1391) and fruit/vegetable intake
(1.5 servings/day, 95% CI 0.3, 2.8) increased. Proportions decreased for convenience meal consumption (−30%,
95% CI −50, −9) and eating out (−22%, 95% CI −44, −0) ≥ 3 times/month. Body mass index and body composition
were unchanged. Fasting (−4.9%, 95% CI −9.5, −0.3) and 2-hour postchallenge (−8.0%, 95% CI −15.6, −0.5) glucose
declined. Insulin sensitivity increased (ISI 0,120 23.7%, 95% CI 9.1, 38.4; Matsuda index 37.5%, 95% CI 3.5, 72.4). Insulin
resistance (HOMA-IR −9.4%, 95% CI −18.6, −0.1) and systolic blood pressure (−3.3%, 95% CI −5.8, −0.8) decreased.
Conclusions: A tailored group intervention appears to lead to improvements in health behaviours and
cardiometabolic risk factors despite unchanged body mass index and body composition. This approach merits
further study.
Clinical trial registration: ClinicalTrials.gov (NCT01814995).
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Women with a gestational diabetes (GDM) history have
a greater than seven-fold risk increase for type 2 dia-
betes [1,2] and increased cardiovascular disease risk
[3,4], compared to women without glucose elevations
in pregnancy. The American Diabetes Prevention Pro-
gram trial (DPP) [5] demonstrated that in prediabetes,
an individualised eating and physical activity behaviour
change program led to a greater than 50% reduction in
type 2 diabetes incidence. Further, impact was specific-
ally confirmed in women within an average of 12 years
of first GDM pregnancy. However, given that the
period of highest diabetes incidence is within 5 years
of a GDM pregnancy [6], the DPP intervention was
arguably “late.” Engaging women earlier could not
only prevent more cases of type 2 diabetes but also
reduce the risk of recurrent GDM [7]. Notably, sub-
sequent pregnancies without GDM are an indicator
of decreased risk of type 2 diabetes development later
in life [8].
Unfortunately, trials within 5 years of a GDM preg-
nancy have met with limited success. Interventions have
mainly been at the individual level, including dietary and
physical activity counselling and support. These have
been delivered through face-to-face consultations with
additional phone/text/email support [9-12] or without
face-to-face contact, relying exclusively on phone calls
and written material [13] or web-based programs [14]. A
single study examined a group-based approach consist-
ing of weekly physical activity sessions [15]. In all cases,
impact on weight was limited [10-14]. When assessed, no
improvements in fasting [10,12,14,15] or 2-hour post chal-
lenge glucose [12,14,15] have been observed. Further,
participation appears to be challenging [15,16], largely
because of work and family-related responsibilities. There
is a need for the development and testing of alternate
strategies, as well as assessment of impact on a greater
variety of cardiometabolic risk factors, to comprehen-
sively capture possible benefits.
As previously reported, we conducted focus group
discussions with women within 5 years of a GDM preg-
nancy, seeking their input on the design of a realistic
intervention strategy. Our analyses signalled a need for
group-based face-to-face interactions with peers and
professionals [17]. However, to facilitate attendance,
on-site childcare was viewed to be important. Phone,
web-based, and text support were considered adjunct-
ive. Spousal involvement was deemed critical to allow
health behavioural change at home. We designed an
intervention that incorporated these elements. We
assessed its impact through the MoMM pilot study,
evaluating not only changes in body weight but in insu-
lin resistance, blood pressure, lipid profile, eating be-
haviours and daily step counts, as reported herein.Subjects and methods
MoMM was a single-arm pilot interventional study
(ClinicalTrials.gov: NCT01814995) examining pre- to post
intervention changes. This design permits each woman
to act as her own control [18]. The protocol was ap-
proved by McGill University’s Faculty of Medicine Insti-
tutional Review Board and all participating institutions
(McGill University Health Centre, Sir Mortimer General
Jewish General Hospital, and Concordia University).
Participants provided written informed consent. The
acronym MoMM originally stood for Combining MOtiv-
ational Support, Meal Preparation Training, and a Taper-
ing Course of Meal Replacements To Achieve Vascular
Risk Reduction in Women with a Gestational Diabetes
History; however, focus group discussion indicated that
women preferred not to use meal replacements. The title
was therefore changed to Mindful mOvement, Mindful
eating, Mindful living.
Eligibility criteria and recruitment
Inclusion criteria were GDM pregnancy within the prior
5 years and BMI ≥ 24 kg/m2. Exclusion criteria were other
forms of diabetes, current use of antihyperglycemic medi-
cation, pregnancy or attempting to become pregnant,
current smoking, or co-morbid conditions or medications
that could impact weight. Recruitment occurred through
the GDM clinics of participating institutions. Strategies in-
cluded invitation letters from the treating physicians with
follow-up telephone calls by study personnel (Additional
file 1: Figure S1).
Intervention
There were four monthly group-based sessions, each
4 hours in duration and held on a weekend day morn-
ing at Concordia University’s PERFORM centre (http://
performcentre.concordia.ca/en/), a research and teach-
ing facility equipped with a kitchen (four work stations)
and an exercise area. Partners were invited to sessions
2 and 4. Experienced childcare providers from a nearby
daycare were hired to supervise the children on-site
during sessions.
Sessions began with a one-hour period with an exercise
physiologist who discussed the importance of physical ac-
tivity and strategies for its integration into the daily rou-
tine. Participants were provided with pedometers and
resistance exercise bands. At the first session, they did a
practice walk with the pedometer and were instructed in
its use. They were encouraged to monitor their daily steps,
aiming to progressively achieve/surpass 10,000 steps/day
[19]. They practiced floor exercises, with and without the
resistance bands, under supervision.
Over the following three hours, a registered dietitian
discussed eating behaviour and nutrition and supervised
participants in the preparation of a balanced meal. They
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strong ‘hunger’ sensations that could provoke over-
eating; to plan intake; to have healthy snacks visible at
home and work (e.g., eat a fruit first); to take the time to
savour meals and snacks with minimal distractions to
help recognition of satiety signals; and to try to eat as a
family. There was an emphasis on appropriate food
group proportions demonstrated using the Canadian
Diabetes Association's Balanced Plate Method (e.g., ½
plate vegetables, ¼ plate cereals and grains, ¼ plate pro-
tein) and the Handy Portion Guide [20]. This was opera-
tionalized when participants and their families served
themselves the meal, under the dietitian’s supervision.
On a separate occasion, participants had an opportunity
to meet with a nutrition student for a grocery store tour,
to discuss produce selection.
The study-specific website included information on
GDM and type 2 diabetes, recipe ideas, stress manage-
ment tips, and links to tools for the tracking of dietary
intake (www.eaTracker.ca) and physical activity (www.
stepscount.com). A discussion forum was available to ad-
dress barriers to achieving healthier choices. Participants
were also contacted individually by telephone two to three
times per month by study personnel, to assess progress
and to respond to any questions.
Outcomes
Demographic information, family history, and past med-
ical history were queried at baseline. All other assessments
were conducted both at baseline and post intervention at
the McGill Nutrition and Performance Laboratory, follow-
ing an overnight fast.
Anthropometric measures and body composition
Weight to the nearest 0.1 kilogram (Digital Physician
Scales, model 140-10-6 by Rice Lake Weighing Systems,
light clothing, shoes removed) and height to the nearest
0.1 centimeter (Stadiometer PE-WM-60-76-BRG2, Per-
spective Enterprises) were assessed and BMI calculated.
Waist circumference was measured midway between the
iliac crest and the lower rib margin. Dual-Energy X-ray
absorptiometry (DXA; GE Lunar Prodigy Advance) was
performed to estimate the percentage of total body fat.
Oral glucose tolerance test and insulin resistance
Plasma glucose (glucose oxidase method) and insulin
(ELISA method) were measured on blood samples drawn
in the fasting state and at 60 and 120 minutes following
ingestion of a 75 g glucose solution. The Homeostatic
Model Assessment Insulin resistance (HOMA-IR) [21],
Matsuda index [22,23], and insulin sensitivity index
(ISI 0, 120) [24] were computed. Other serum markers.
Lipid parameters (Total-cholesterol, HDL, Triglycerides)
were measured on fasting blood samples (Piccolo xpresstechnic) and LDL was calculated. Adiponectin and leptin
concentrations were assayed (Human Total Adiponectin/
Acrp30 Quantikine ELISA Kit, cat. DRP300, R&D systems;
Human Leptin Quantikine ELISA Kit, cat. DLP00, R&D
systems). Blood pressure. Blood pressure was assessed
in a seated position with the arm supported following a
5-minute rest period. Six measurements at 1-minute
intervals were recorded (Mindray Accutor –V Vital
Signs Monitor). The last 5 systolic (SBP) and diastolic
blood pressure (DBP) measurements were separately
averaged.Dietary intake and eating behaviour
A registered dietitian conducted 24-hour dietary recalls
to determine number of daily servings by food group
(Canada Food Guide) [25]. Participants were asked
about the frequency of eating pre-prepared conveni-
ence foods or restaurant meals [26]. Perceived ability
to cook from basic ingredients was assessed (7-point
scale) [27]. Other self-administered questionnaires in-
cluded the Weight Efficacy Lifestyle (WEL) [28] which
assesses eating-related self control (scores 1–9) and the
Mindful Eating Questionnaire (MEQ) [29] (scores 1 to 4).
The Weight Stages of Change-Short Form was also
administered [30].Physical activity behaviour
Daily step counts were measured using Yamax SW-200
(Yamasa Tokei Keiki Co., Ltd, Tokyo, Japan) pedometers
over 7 days [31]. Participants also wore a multi-axial ac-
celerometer (ActiGraph GT3X, Actigraph LLC., Pensa-
cola, FL). To be included in the analysis, participants
had to have worn the accelerometer for at least 10 hours
per day for a minimum of 3 days. Other. Participants
completed the Hospital Anxiety and Depression Scale
(HADS, 14 items) [32]. At the time of the final evalu-
ation, participants completed a questionnaire querying
utility of the sessions, with specific questions about the
cooking and physical activity components, the importance
of on-site childcare, reasons for partner’s attendance/non-
attendance, utility of the eaTracker tool, pedometer, ped-
ometer step count tracker tool, and MoMM website, as
well as suggestions about ways to improve the website.Statistical analysis
Descriptive statistics are presented as means and stand-
ard deviations (SD), median and interquartile range (IQR),
or proportions, as appropriate. Mean changes and 95%
confidence intervals were calculated in unit and per-
centage change from baseline for clinical and behav-
ioural parameters.
Table 1 Participation during the 13-week intervention
Intervention components
Sessions attendance
Four sessions; n (%) 9 (33.3%)
Three sessions; n (%) 11 (40.7%)
Two sessions; n (%)* 6 (22.2%)
Child-care use
Ever use; n (%) 24 (88.9%)
Sessions used among those with ever use
(% of attended sessions)
100%
Partners' attendance†
One session; n (%) 7 (28.0%)
Two sessions; n (%) 3 (12.0%)
Grocery store visit
Signed up to participate; n (%) 7 (25.9%)
Participated; n (%) 2 (7.4%)
Web-use
Visited website; n (%) 23 (85.2%)
Visits to website, median (IQR) 21 (8.4-44.5)
Use of step count log; n (%) 14 (51.9%)
Use of eaTracker; n (%) 16 (59.3%)
Visited web-forum; n (%) 13 (48.1%)
Posted comments on web-forum; n (%) 2 (7.4%)
Contact by Participants with MoMM coordinator
Contacted by email; n (%) 25 (92.6%)
Emails sent by participants; median (IQR) 5.5 (5.5-15.5)
Contacted by text messages; n (%) 4 (3.7%)
*Two women were recruited after the first group session; they participated in
two out of three sessions.




















Figure 1 Daily servings compared to the Canada’s Food Guide.
Data are means and 95% Confidence intervals. Black bars = baseline
values; White bars = final values; Hatched white bars = Canada Food
Guide recommendation. * A portion of added sugar = 5 g
of carbohydrate.
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Thirty-six women were recruited. Among these, 27
(75.0%) completed baseline and final assessments.
Among the 9 women that withdrew, 5 did not attend
any group-sessions (new pregnancy, 2; divorce or death
in family, 2; unspecified, 1) and 4 attended at least one
(time pressure, 2; feeling depressed, 1; divorce, 1). Those
who completed both assessments were, on average, ap-
proaching their middle years (mean age 40 years, SD 5)
and educated beyond high school (88.9%). More than half
(63.0%) were Europid, most lived with their partner
(92.6%), had an average of two children, and worked out-
side the home (74.1%). Questionnaire data indicated that 5
(18.5%) had elevated anxiety levels and one had depressed
mood (3.7%). Roughly half reported limited social media
use (never, 18.5%; monthly, 33.3%). At baseline, most were
in an action (44.4%) or maintenance (18.5%) stage for
weight change.
Four women (14.8%) were included in the study al-
though their BMIs were < 24 kg/m2, (i.e., did not meet
eligibility criteria). We opted to include them because
of recruitment challenges. Three (11.1%) more had a
BMI between 24 and 25 kg/m2, 10 (37.0%) were over-
weight (25 ≤ BMI < 30 kg/m2) and 10 (37.0%) were
obese (BMI ≥ 30 kg/m2). Eleven (37.0%) met criteria
for dysglycemia (3 impaired fasting glucose alone, 1
impaired glucose tolerance alone, 6 impaired fasting
glucose and impaired glucose tolerance, 1 type 2 dia-
betes). We opted to retain the individual with type 2
diabetes but performed a sensitivity analysis excluding
this individual.
Roughly one third (33.3%, Table 1) who completed
baseline and final assessments attended all in-person
sessions. Approximately half (48.1%) missed a single ses-
sion. Most used the free on-site childcare (88.9%) at all
sessions that they attended. Among the 25 (92.6%) who
lived with a partner, 10 (40.0%) had a partner who
attended at least one session. Almost all participants
(85.2%) visited the MoMM website. Half (51.9%) used
the on-line step count-tracking tool and logged onto the
eaTracker tool (59.3%). Participants emailed the staff-
contact a median of 5.5 times (IQR 5.5-15.5) over the
course of the study.
Dietary intake, eating behaviours, and physical activity
Most (n = 19; 73%) perceived themselves to be at least
a competent cook at baseline. This increased to 77.8%
(n = 21) post intervention. Fruit and vegetable consump-
tion increased from 3.7 (SD 2.7) servings/day at baseline
to 5.2 (SD 3.4) at the final evaluation (mean increase: 1.5
servings/day, 95% CI 0.3, 2.8) (Figure 1). The proportion
of participants consuming pre-prepared convenience
meals more than three times per month declined from
48% at baseline to 19% post intervention (−30%, 95%
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than three times per month decreased from 50% at
baseline to 30% post intervention (−22%, 95% CI −44, 0).
There were no important changes in the WEL or MEQ
scores. There were no important changes in accelerometer-
based measures of physical activity, but only 20 participants
wore their accelerometer the required ≥ 10 hours per
day for at least during 3 days. In contrast, pedometer
data indicated that by the end of the program, women
were completing an additional 733 steps/day (95% CI
85, 1391) reaching a mean of 7,762 (SD 2368). This
change corresponds to an 18.8% improvement (95% CI
6.6, 20.9).
Weight and body composition
The mean weight loss (Table 2) was −0.2 kg of total body
weight (95% CI −1.0, 0.5) and −0.1 kg of total fat mass
(95% CI −0.8, 0.5). Glucose tolerance. There were mean re-
ductions in FPG (−0.3 mmol/L, 95% CI −0.6, −0.0) and in
2hPG (mean −0.7 mmol/L, 95% CI −1.4, −0.1) values
(Table 2; Figure 2). The participant with a new diagnosis
of type 2 diabetes had reductions in both FPG, from 8.5 to
5.2 mmol/L, and in 2hPG, from 16.5 to 11.2 mmol/L,
without institution of any antihyperglycemic medication.Table 2 Changes in cardiometabolic measures




Weight, kg 77.1 (19.0) 76.4 (17.1)
Body mass index, kg/m2 29.3 (7.0) 29.1 (6.7)
Waist circumference, cm 92.7 (14.6) 91.8 (13.7)
Fat mass, %* 40.7 (7.1) 41.7 (6.7)
Systolic blood pressure, mm Hg 119.6 (11.2) 120.0 (11.2)
Diastolic blood pressure, mm Hg 70.4 (6.7) 71.3 (6.9)
Fasting plasma glucose, mmol/L 5.7 (0.8) 5.8 (0.8)
1-h plasma glucose, mmol/L 9.5 (2.9) 9.8 (3.1)
2-h plasma glucose, mmol/L† 7.2 (2.9) 7.6 (3.3)
Fasting insulin, μU/mL 7.9 (4.5) 8.5 (4.9)
1-h insulin, μU/mL* 88.7 (80.0) 101.7 (88.8)
2-h insulin, μU/mL† 63.5 (65.0) 75.7 (72.7)
ISI 0,120, mg × L
2/mmol × μU ×min† 56.6 (26.3) 59.3 (31.9)
Matsuda Index† 5.6 (3.9) 5.0 (4.0)
HOMA-IR 2.0 (1.3) 2.2 (1.4)
Total Cholesterol, mmol/L 5.0 (0.7) 4.9 (0.6)
HDL-cholesterol, mmol/L 1.3 (0.3) 1.3 (0.3)
LDL-cholesterol, mmol/L 3.0 (0.6) 2.9 (0.6)
Triglycerides, mmol/L 1.4 (0.8) 1.5 (0.9)
Adiponectin, μg/mL 6.8 (4.4) 6.6 (4.0)
Leptin, ng/mL 25.2 (16.7) 23.6 (13.8)
*Data available for 26 who completed baseline and final assessments.
†Data available for 25 who completed baseline and final assessments.Measures of insulin resistance and sensitivity. Insulin re-
sistance, as captured by HOMA-IR, decreased by a mean
of −0.2 (95% CI −0.5, 0.0), nearly a 10% reduction (−9.4%,
95% CI −18.6, −0.1). Correspondingly, there were in-
creases in both measures of insulin sensitivity. The
Matsuda index increased by a mean of 1.5 (95% CI −0.3,
3.3), a 37.9% increase (95% CI 3.5, 72.4). The ISI0,120 in-
creased by a mean of 13.1 mg × L2/mmol × μU×min (95%
CI 5.0, 21.2), a 23.7% increase (95% CI 9.1, 38.4). Women
in all BMI categories demonstrated a similar trend for glu-
cose tolerance change (Additional file 1: Table S1). In a
sensitivity analysis excluding the individual with type 2
diabetes retained, the point estimates were unchanged but
the confidence intervals slightly widened (e.g. 2hPG went
from −8.0% [95% CI −15.6, −0.5] to −7.6% [95% CI −14.6,
0.5] and ISI0,120 from 23.7% [95% CI 9.1, 38.4] to 22.4%
[95% CI 7.4, 37.4)]. Blood pressure. There were reductions
in both SBP (−4.2 mmHg, 95% CI −7.4, −1.0) and in DBP
(−3.1 mmHg, 95% CI −5.3, −0.9). Lipid profile. Triglycer-
ides were also lower post intervention (−0.4 mmol/L, 95%
CI −0.4, −0.1), but other lipid parameters (HDL, LDL and
Total-Cholesterol) remained unchanged. Adiponectin and
leptin. Changes for adiponectin and leptin values were in-




76.2 (17.2) −0.3% [−1.3, 0.7]
29.0 (6.8) −0.3% [−1.3, 0.7]
90.8 (13.6) −0.9% [−2.6, 0.7]
41.5 (7.0) −0.5% [−2.0, 1.1]
115.8 (11.4) −3.3% [−5.8, −0.8]
68.2 (8.4) −4.3% [−7.3, −1.3]
5.5 (0.9) −4.9% [−9.5, −0.3]
9.1 (3.6) −5.0% [−19.1, 9.1]
6.8 (2.8) −8.0% [−15.6, −0.5]
8.1 (5.0) −5.3% [−13.3, 2.7]
82.5 (46.3) −2.2% [−24.9, 20.6]
55.0 (50.2) −15.9% [−35.6, 3.8]
72.3 (41.4) 23.7% [9.1, 38.4]
6.5 (6.4) 37.9% [3.5, 72.4]
2.0 (1.3) −9.4% [−18.6, −0.1]
4.8 (0.7) −1.9% [−4.9, 1.1]
1.3 (0.4) 0.0% [−4.0, 4.0]
2.9 (0.5) 2.1% [−2.4, 6.7]
1.30 (0.7) −9.7% [−20.2, 0.9]
6.7 (4.0) 2.2% [−3.7, 8.1]


































   
   
   
   
   
   






PG (mmol/L) 6.1 8.6 7.8
Baseline         9 / 27 18 / 27 7 / 25
Final              7 / 27 14 / 27 6 / 25
Figure 2 Plasma glucose and plasma insulin during the oral
glucose tolerance tests. Black line = baseline; Hatched line = final.
PG = Plasma glucose. Data are means and 95% confidence intervals.
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Twenty-three participants completed the post intervention
questionnaire related to impressions/opinions related to
the intervention strategy. There was strong indication that
participants perceived sessions as useful in promoting
eating behaviour change (92%). The incorporation of
‘hands-on’ cooking was deemed important (88%) and in-
dication that the physical activity education sessions
helped increase activity levels (92%). A large proportion
indicated that the pedometer was a useful tool (92%).
Many noted that the availability of on-site childcare facili-
tated session attendance (79%). In terms of partner attend-
ance, 9% did not have a partner and 70% indicated that
their partner could not attend (35%- no time; 35%- did
not want to attend).
In terms of on-line tools, over half (56%) indicated that
the MoMM website was useful to them, 44% reported
the on-line step count log to be helpful, and 40% appre-
ciated the eaTracker tool. Conversely, an important pro-
portion reported never logging on to these sites/tools
(32% for MoMM website, 40% for on-line step count
log, 36% for eaTracker). Some individuals did log on but
did not perceive the tools to be useful (12% for MoMM
website, 16% for on-line step count log, 24% for eaTracker);
these individuals either experienced frustrations/challenges
with the sites (amount of information, errors, juggling
passwords- four responses), preferred to use paper and
pencil tracking (three responses), or may have preferred
a Facebook page (one comment).
Discussion
Among women within 5 years of a GDM pregnancy who
participated in a 13-week tailored intervention (i.e., 4group sessions, partners invited to two, on-site childcare,
meal preparation, pedometers and floor exercises), at-
tendance at sessions was high, the childcare service and
website were used, and there was some spousal partici-
pation. Self-reported eating control was not enhanced
and there were no changes in BMI or body composition.
However, there were important increases in fruit and
vegetable intake and consumption of both convenience
meals and eating out declined. Step counts also increased.
There were reductions in both fasting and 2-hour post-
challenge glucose and improvements in all measures of in-
sulin resistance and sensitivity. There was also lowering of
both systolic and diastolic blood pressure and triglycerides.
On balance, the tailored intervention demonstrated both
behavioural and biological impact and thus merits further
study and development.
Less than a fifth of the participants missed 2 or more
of the 4 sessions. On-site childcare may have been a key
facilitating factor as evidenced by high use, with almost
90% of the women using it at every session they attended.
Further, monthly sessions may have also enhanced at-
tendance, being realistically aligned with time availabil-
ity. Indeed, in a comprehensive lifestyle change study
post pregnancy in a non GDM population, participants
were able to attend only 4 of 10 scheduled sessions [16].
Higher attendance had been observed in studies with
phone-based or at home sessions, and if sessions are
scheduled at the same time of routine medical follow-
up [33,34]. For example, among women with GDM who
were recruited during pregnancy, 79% completed, during
pregnancy, ≥ 2 out of 3 sessions (i.e., 1 in-person and 2
telephone counselling calls) and, in the postpartum period,
they participated in an average of 9.4 sessions out of a
maximum of 15 (i.e., a maximum of 2 in-persons and a
maximum of 13 telephone counselling calls) [9]. We
would note, however, that our participants expressed
strong endorsement of in-person group sessions and
had high levels of attendance.
In the focus group discussions that helped us to design
the intervention [17], women expressed a need for spousal
involvement. A need for spousal involvement to achieve
changes in health behaviour has also emerged in other
qualitative studies conducted among women with a GDM
history [35,36]. Spousal participation was not a com-
ponent of previous intervention studies [9-13,15]. The
attempt to involve spouses is a novel aspect of our
intervention. While we did invite spouses to two of the
four intervention sessions and there was some partici-
pation, a large proportion of spouses did not attend
any sessions. Better engagement may further enhance
health behaviour change. While time constraints are a
real challenge, lack of interest could potentially be ad-
dressed with better knowledge about personal and familial
diabetes risks related to eating and physical activity habits
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analysis [37] estimated that type 2 diabetes in one spouse
is associated with a 26% increased risk for type 2 diabetes
in the other; further, studies that performed blood tests
systematically indicated a doubling of diabetes risk. The
concept of shared diabetes risk may potentially be lev-
eraged to increase engagement of spouses in diabetes
prevention efforts.
Our post-intervention questionnaire related to impres-
sions/opinions on the intervention strategy suggests a high
level of endorsement for in-person, hands-on compo-
nents, and pedometer use. The availability of on-site child-
care was a clear facilitator. While a substantial proportion
did use the on-line tools and website, this was much less
than in-person session participation. This may not be sur-
prising given that half of participants reported not using
web-based media frequently (i.e., less than monthly) at
baseline. Web-based tools appear to be underutilised by
this group of adults. In a web-based pedometer interven-
tion in women with a GDM history, Kim and colleagues
[14] noted that only 3 out of 21 participants used the web
forum and questions were only directed to the study
staff. This is unfortunate given the low cost and con-
venience of web and text-based communications. Future
studies may need to incorporate strategies to facilitate web-
based communication and engagement. For example, study
personnel may need to proactively encourage web-based
discussion among participants.
The 1.5 servings/day increase in fruit and vegetable
intake that we observed likely contributed to the cardio-
metabolic benefits realized (i.e., glucose, insulin resist-
ance and sensitivity, triglycerides, blood pressure). In a
cross-sectional study on 2,115 adults at risk for diabetes,
a two-serving increase in daily fruit and vegetable con-
sumption was associated with a 0.08 mmol/L reduction in
FPG and 0.2 mmol/L reduction in 2hPG [38]. In a pooled
analysis of three prospective cohort studies, fruit con-
sumption was associated with a lower risk of type 2
diabetes (Hazard Ratio 0.98, 95% CI 0.97, 0.99 for three
servings/week increment of total whole fruit consump-
tion) [39]. Consistent with the protective effects of
fruits and vegetables, diabetes risk calculators, such as
FINDRISC, include daily vegetables, fruits and berries
consumption as a factor that protects against diabetes
development [40]. Moreover, specifically among women,
the European Prospective Investigation into Cancer and
Nutrition study demonstrated that a 0.5 serving increase
in daily intake of vegetables to be associated with 0.20 and
0.09 mm Hg reductions in SBP and DBP, respectively [41].
As reviewed in a meta-analysis of randomised controlled
trials, a 10 mm Hg reduction in SBP or 5 mm Hg re-
duction in DBP leads to a 22% reduction in coronary
heart disease events and a 41% reduction in stroke [42].
Our participants achieved mean reductions of morethan 4 mm Hg in SBP and 3 mm Hg in DBP, clinically-
important changes.
We observed a 733 steps/day increase, greater than that
observed in a 12-week web-based pedometer program
(mean 543, SD 2074) in women with a GDM history [14].
Among NAVIGATOR trial participants (Nateglinide and
Valsartan in Impaired Glucose Tolerance Outcomes Re-
search), both step counts at baseline and mean 6-year
increases were associated with reductions in occurrence
of cardiovascular events [43]. Our previous studies have
demonstrated inverse relationships between blood pres-
sure and step counts, particularly in women [44]. The
increase in step counts thus likely also contributed to
the cardiometabolic improvements we observed in the
present study.
The mean improvements that we observed in FPG and
2hPG are at least as great as those observed in the Finnish
Diabetes Prevention trial (−0.3 mmol/L FPG; −0.8 mmol/L
2hPG) [45]. Given that the Finnish Diabetes Prevention
Trial, like the DPP, achieved major reductions in diabetes
incidence through a lifestyle intervention, the compar-
ability of the improvement in 2-hour post 75 g glucose
challenge that we observed appears promising. Further,
computations of insulin resistance and sensitivity derived
from glucose and insulin measurements consistently dem-
onstrated improvements (HOMA-IR, ISI0,120, Matsuda
index). Notably, higher insulin sensitivity estimated with
the Matsuda index is associated with a decreased inci-
dence of diabetes in high-risk populations [46].
We acknowledge several limitations. First, the primary
outcome of our study was a change in weight but no
important weight reduction was achieved. More em-
phasis on energy expenditure reduction may have led
to greater weight changes, although adherence may
have been challenging. Although our target population
was overweight women within 5 years of a GDM preg-
nancy, some of the women enrolled had a normal BMI.
Nonetheless, the BMI range of participants enrolled
was more representative of women with GDM in general
[47]. Weight reduction observed in overweight/obese
women alone was also modest −0.5% (95% CI: −1.7, 0.8),
and other changes observed in normal-weight weight
women were similar to those observed in the rest of the
participants (Additional file 1: Table S1). Second, recruit-
ment was challenging, as anticipated. We endeavoured to
recruit women within 5 years of a GDM diagnosis. This is
a period of high risk for conversion to type 2 diabetes [6].
While interventions even closer to the time of GDM diag-
nosis may have had even greater potential impact [6], it
would have rendered recruitment more challenging. As
reported in our previous focus group study, more than
1,000 invitation letters were sent to women with a prior
GDM history. From this pool, we were able to enroll 29 in
our focus group study and 28 in the intervention study,
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The women enrolled may thus not be representative of all
women within 5 years of a GDM pregnancy, although they
may be representative of those willing to engage in pre-
vention efforts. For capturing dietary intake, the use of a
single 24-hour dietary intake recall limits the analysis of
macronutrients and micro-nutrients intake (e.g., sodium)
that may have impacted cardiometabolic risk factors
but does provide an overall view of dietary intake.
Accelerometry-based measurements were limited by
low wear-time in this cohort. Finally, the lack of a control
group is a limitation for this study. A large randomized
controlled trial design would be better able to confirm
that the cardiometabolic improvements and behavioural
changes observed were attributable to the intervention.
We plan to conduct such a study.
In summary, the MoMM pilot study indicates that,
among women who enroll and participate, a group-based
multimodal intervention with childcare support may be
effective in lowering diabetes and vascular disease risk
in women within 5 years of a GDM pregnancy. Building
on such an approach has the potential to reduce diabetes
risk and vascular complications- in mothers, fathers, and
children.
Additional file
Additional file 1: Table S1. Baseline values and percentage of changes
from baseline by baseline weight category. Figure S1. Recruitment’s flow
chart.
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